Eversept Partners »

Surrozen shares owned by Eversept Partners

Quarter-by-quarter ownership of Surrozen (SRZN) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Surrozen

Tip: Access up to 7 years of quarterly data

All positions including Surrozen held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Surrozen by Eversept Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $992k 77k 12.89

More positions owned by Eversept Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Natera (NTRA)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Uniqure Nv SHS (QURE)
Hca Holdings (HCA)
Miragen Therapeutics (VRDN)
Zimvie (ZIMV)
Abivax Sa Sponsored Ads (ABVX)
Ionis Pharmaceuticals (IONS)
PerkinElmer (RVTY)
Travere Therapeutics (TVTX)

View all positions for Eversept Partners

Top funds holding Surrozen

Stempoint Capital
VR Adviser
RA Capital Management
5AM Venture Management
Vanguard Group
Vivo Capital
Stonepine Capital Management
Samsara BioCapital
Nantahala Capital Management
Longwood Capital Partners
Braidwell
Regents of the University of California
Millennium Management
Adage Capital Partners GP
Euclidean Capital

View all funds holding Surrozen